Meta Financial Group Inc. (CASH) Reaches $72.20 After 5.00% Down Move; Shorts at Varian Medical Systems (VAR) Lowered By 6.11%

July 28, 2017 - By Dolores Ford

Varian Medical Systems Incorporated (NYSE:VAR) had a decrease of 6.11% in short interest. VAR’s SI was 7.28M shares in July as released by FINRA. Its down 6.11% from 7.76M shares previously. With 758,500 avg volume, 10 days are for Varian Medical Systems Incorporated (NYSE:VAR)’s short sellers to cover VAR’s short positions. About 139,734 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since July 28, 2016 and is uptrending. It has outperformed by 12.76% the S&P500.

The stock of Meta Financial Group Inc. (NASDAQ:CASH) is a huge mover today! About 205,618 shares traded or 349.23% up from the average. Meta Financial Group Inc. (NASDAQ:CASH) has risen 72.00% since July 28, 2016 and is uptrending. It has outperformed by 55.30% the S&P500.The move comes after 5 months negative chart setup for the $674.76M company. It was reported on Jul, 28 by Barchart.com. We have $68.59 PT which if reached, will make NASDAQ:CASH worth $33.74M less.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company has market cap of $8.99 billion. The Firm also has Varian Particle Therapy and the activities of the Ginzton Technology Center (GTC). It has a 31.45 P/E ratio. The Company’s VPT business develops, designs, makes, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer.

Since February 22, 2017, it had 0 insider buys, and 14 sales for $12.71 million activity. KUO JOHN W sold $83,084 worth of stock or 862 shares. Another trade for 1,428 shares valued at $147,761 was sold by LARET MARK R. Another trade for 16,000 shares valued at $1.65 million was made by GUERTIN TIMOTHY E on Friday, June 9. Shares for $326,902 were sold by BOSTROM SUSAN L. On Thursday, June 1 KENNEDY KOLLEEN T sold $5.64M worth of Varian Medical Systems, Inc. (NYSE:VAR) or 56,573 shares.

Investors sentiment increased to 0.9 in Q4 2016. Its up 0.01, from 0.89 in 2016Q3. It improved, as 38 investors sold Varian Medical Systems, Inc. shares while 188 reduced holdings. 59 funds opened positions while 144 raised stakes. 88.84 million shares or 2.22% less from 90.86 million shares in 2016Q3 were reported. Nuance Ltd Com reported 0.42% in Varian Medical Systems, Inc. (NYSE:VAR). Srb Corporation reported 1,915 shares. 7 were accumulated by Parkside Savings Bank & Tru. Quantitative Inv Limited Liability Corp stated it has 13,600 shares or 0.03% of all its holdings. Arizona State Retirement Systems invested in 62,652 shares or 0.08% of the stock. Finemark Comml Bank & holds 1,881 shares. Global X Mngmt Ltd Liability invested in 0.03% or 6,413 shares. Cape Cod Five Cents National Bank holds 26,437 shares or 0.42% of its portfolio. 4,450 were reported by Parkwood Ltd Liability Company. Boys Arnold & Company holds 0.09% or 5,710 shares. Proshare Advisors Limited Liability Corp holds 9,281 shares or 0.01% of its portfolio. Webster State Bank N A owns 2,358 shares. Lakeview Cap Prns Limited Company reported 0.23% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Vident Advisory Lc holds 14,681 shares. Franklin Resources holds 360,570 shares.

Among 10 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Varian Medical Systems Inc. had 21 analyst reports since August 27, 2015 according to SRatingsIntel. Goldman Sachs downgraded it to “Sell” rating and $76 target in Monday, September 28 report. The firm has “Neutral” rating given on Thursday, November 12 by Citigroup. The rating was downgraded by Robert W. Baird on Tuesday, October 20 to “Neutral”. Barrington Research reinitiated Varian Medical Systems, Inc. (NYSE:VAR) rating on Tuesday, January 12. Barrington Research has “Outperform” rating and $91 target. The firm earned “Hold” rating on Monday, July 24 by RBC Capital Markets. RBC Capital Markets maintained the shares of VAR in report on Thursday, April 27 with “Sector Perform” rating. The stock has “Outperform” rating by Barrington Research on Friday, January 27. Jefferies maintained the shares of VAR in report on Friday, July 14 with “Buy” rating. The stock of Varian Medical Systems, Inc. (NYSE:VAR) earned “Buy” rating by Brean Capital on Thursday, April 28. On Wednesday, June 21 the stock rating was maintained by RBC Capital Markets with “Hold”.

Analysts await Meta Financial Group Inc. (NASDAQ:CASH) to report earnings on August, 1. They expect $1.19 EPS, up 14.42% or $0.15 from last year’s $1.04 per share. CASH’s profit will be $11.12M for 15.17 P/E if the $1.19 EPS becomes a reality. After $4.11 actual EPS reported by Meta Financial Group Inc. for the previous quarter, Wall Street now forecasts -71.05% negative EPS growth.

Meta Financial Group, Inc. is a unitary savings and loan holding company. The company has market cap of $674.76 million. The Firm operates through its banking subsidiary, MetaBank . It currently has negative earnings. The Company’s divisions include Payments, Banking, and Corporate Services/Other.

Investors sentiment decreased to 1.93 in Q4 2016. Its down 0.59, from 2.52 in 2016Q3. It fall, as 10 investors sold Meta Financial Group Inc. shares while 36 reduced holdings. 40 funds opened positions while 49 raised stakes. 6.29 million shares or 5.28% more from 5.98 million shares in 2016Q3 were reported. Pnc Fincl Group reported 38,767 shares. Acadian Asset Management Ltd reported 6,889 shares or 0% of all its holdings. Raymond James And Associate holds 0% or 12,954 shares. 4,530 were reported by Smith Asset Mngmt Limited Partnership. The New York-based Secor Advsrs L P has invested 0.17% in Meta Financial Group Inc. (NASDAQ:CASH). Financial Bank Of Ny Mellon stated it has 50,643 shares. Blackrock Limited Liability Corp reported 0% stake. Bnp Paribas Arbitrage Sa has invested 0% in Meta Financial Group Inc. (NASDAQ:CASH). New Jersey-based Jacobs Levy Equity Management has invested 0.02% in Meta Financial Group Inc. (NASDAQ:CASH). Guggenheim Cap Ltd Liability Corporation stated it has 12,451 shares or 0% of all its holdings. Bogle Investment Management Limited Partnership De reported 14,690 shares. Emerald Advisers Inc Pa holds 0.01% or 3,161 shares in its portfolio. Ftb Advisors Incorporated accumulated 44 shares or 0% of the stock. Alliancebernstein Lp reported 10,000 shares stake. United Automobile Association, Texas-based fund reported 8,200 shares.

Since February 6, 2017, it had 1 insider purchase, and 8 selling transactions for $2.23 million activity. 1,000 shares were bought by Hoople Elizabeth G., worth $83,630 on Monday, May 15. HAAHR J TYLER sold $481,102 worth of stock or 5,000 shares. $40,113 worth of Meta Financial Group Inc. (NASDAQ:CASH) was sold by Hajek Douglas J.. Moore Frederick V had sold 300 shares worth $26,175.

Among 4 analysts covering Meta Financial Group (NASDAQ:CASH), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Meta Financial Group had 7 analyst reports since October 13, 2015 according to SRatingsIntel. The stock of Meta Financial Group Inc. (NASDAQ:CASH) earned “Buy” rating by FBR Capital on Thursday, June 1. The rating was upgraded by Sandler O’Neill to “Buy” on Tuesday, October 13. The stock has “Outperform” rating by Wood on Thursday, April 7. Keefe Bruyette & Woods maintained Meta Financial Group Inc. (NASDAQ:CASH) on Monday, June 26 with “Buy” rating. FBR Capital downgraded Meta Financial Group Inc. (NASDAQ:CASH) on Friday, July 28 to “Hold” rating. The stock of Meta Financial Group Inc. (NASDAQ:CASH) earned “Outperform” rating by Wood on Monday, August 15. FBR Capital initiated Meta Financial Group Inc. (NASDAQ:CASH) rating on Tuesday, January 10. FBR Capital has “Outperform” rating and $130 target.